Literature DB >> 16421770

The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?

A R Porcalla1, C A Sable, K M Patel, G R Martin, N Singh.   

Abstract

The etiology and pathogenesis of Kawasaki disease (KD) is largely unknown. Certain demographic factors and laboratory findings are predictive of the development of coronary artery (CA) aneurysms. The objectives of this study were to determine the epidemiology of KD patients in an urban hospital and determine risk factors associated with their development of CA abnormalities. A longitudinal case series of KD patients admitted to Children's National Medical Center from 1990 to 2002 was examined. Age, sex, ethnic background, duration of fever prior to diagnosis, address, month diagnosed, and CA abnormalities (ectasia or aneurysms) on echocardiography were recorded. Median household income was obtained from the U.S. Census Bureau Web site. The Student t-test, logistic regression analyses, and the Kruskal-Wallis test were used, with significance assumed at p < 0.05. A total of 302 patients were evaluated. CA abnormalties were found in 27 patients (9%), with aneurysms identified in 13 patients (4%). Age was 2.9 +/- 2.4 years (range, 2 months to 14 years). A total of 51 patients (16%) were < or =1 year and 35 patients (12%) were > or =5 years. Ethnic distribution was 54% (164) African American, 24% (72) Caucasian, 9% (29) Asian/Pacific Islander, 8% (23) Hispanic, and 5% (14) Middle Eastern. Only 2/164 (1.2%) African Americans developed CA aneurysms. Neighborhood median income of the cohort was $45,400 +/- $21,200 ($52,200 +/-$25,800 for patients with aneurysms). A total of 28% of cases clustered between December and January. Cases doubled annually in 1999-2001 compared to 1990-1998 (39 vs 19). Multivariate logistic regression found age between 1 and 5 years [p = 0.045; odds ratio, 0.31; 95% confidence interval (CI), 0.10-0.97] and African American race (p = 0.014; odds ratio, 0.15; 95% CI, 0.03-0.68) to be independently protective against CA aneurysms. Duration of fever prior to diagnosis, considered in 210 patients, was different between patients with and without aneurysms (11 +/- 5.3 vs 6.5 +/- 3.8 days, respectively, p = 0.0007). Multivariate logistic regression found fever longer than 5 days to be the only predictive factor associated with the development of aneurysms and any abnormality. African Americans had a shorter duration of fever than the rest of the cohort (6.03 vs 7.31 days), (p = 0.0087). The epidemiology of KD at our hospital is similar to that at other centers except for the predominance of African Americans with a shorter duration of fever prior to diagnosis and a decreased incidence of CA aneurysms compared to other ethnicities. The protective nature of African American ethnicity against the development of CA aneurysms raises speculation about the role of genetics and its interaction with immunity in the pathogenesis of KD.

Entities:  

Mesh:

Year:  2005        PMID: 16421770     DOI: 10.1007/s00246-005-0916-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  36 in total

1.  TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis.

Authors:  Janardan P Pandey; Margaret Frederick
Journal:  Hum Immunol       Date:  2002-06       Impact factor: 2.850

2.  Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset.

Authors:  M Fukunishi; M Kikkawa; K Hamana; T Onodera; K Matsuzaki; Y Matsumoto; J Hara
Journal:  J Pediatr       Date:  2000-08       Impact factor: 4.406

3.  Incidence survey of Kawasaki disease in 1997 and 1998 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; I Oki; S Hirata; T Zhang; T Kawasaki
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

4.  Immunoglobulin allotypic markers in Kawasaki disease.

Authors:  S T Shulman; M Melish; O Inoue; H Kato; S Tomita
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

Review 5.  Kawasaki disease: A brief history.

Authors:  J C Burns; H I Kushner; J F Bastian; H Shike; C Shimizu; T Matsubara; C L Turner
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

6.  The incidence of Kawasaki syndrome in West Coast health maintenance organizations.

Authors:  E D Belay; R C Holman; M J Clarke; F Destefano; A Shahriari; R L Davis; P H Rhodes; R S Thompson; S B Black; H R Shinefield; S M Marcy; J I Ward; J P Mullooly; R T Chen; L B Schonberger
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

7.  Relation of streptococcal pyrogenic exotoxin C as a causative superantigen for Kawasaki disease.

Authors:  Takeshi Yoshioka; Takaji Matsutani; Tomoko Toyosaki-Maeda; Hiroyuki Suzuki; Sigeru Uemura; Ryuji Suzuki; Michio Koike; Yorio Hinuma
Journal:  Pediatr Res       Date:  2003-03       Impact factor: 3.756

Review 8.  Chronic hepatitis C in African Americans and other minority groups.

Authors:  Jaquelyn Fleckenstein
Journal:  Curr Gastroenterol Rep       Date:  2004-02

9.  Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.

Authors:  Robert C Holman; Aaron T Curns; Ermias D Belay; Claudia A Steiner; Lawrence B Schonberger
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

10.  Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population.

Authors:  S T Shulman; J B McAuley; L M Pachman; M L Miller; D G Ruschhaupt
Journal:  Am J Dis Child       Date:  1987-04
View more
  15 in total

Review 1.  Imaging studies in the diagnosis and management of vasculitis.

Authors:  Luis M Amezcua-Guerra; Carlos Pineda
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

2.  Kawasaki disease presenting with intussusception: a case report.

Authors:  Rumana N Hussain; Gary Ruiz
Journal:  Ital J Pediatr       Date:  2010-01-19       Impact factor: 2.638

3.  Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.

Authors:  Michael A Portman; Nagib S Dahdah; April Slee; Aaron K Olson; Nadine F Choueiter; Brian D Soriano; Sujatha Buddhe; Carolyn A Altman
Journal:  Pediatrics       Date:  2019-05-02       Impact factor: 7.124

Review 4.  Coronary CT Angiography to Guide Percutaneous Coronary Intervention.

Authors:  Georgios Tzimas; Gaurav S Gulsin; Hidenobu Takagi; Niya Mileva; Jeroen Sonck; Olivier Muller; Jonathon A Leipsic; Carlos Collet
Journal:  Radiol Cardiothorac Imaging       Date:  2022-01-06

Review 5.  Systemic vasculitis in childhood.

Authors:  Abraham Gedalia; Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

6.  Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.

Authors:  Brady S Moffett; Dorothy Syblik; Susan Denfield; Carolyn Altman; Kristin Tejtel-Sexson
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

Review 7.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

Review 8.  Aneurysmal coronary artery disease: An overview.

Authors:  Mohamed S ElGuindy; Ahmed M ElGuindy
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

Review 9.  Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment.

Authors:  Sara Abou Sherif; Ozge Ozden Tok; Özgür Taşköylü; Omer Goktekin; Ismail Dogu Kilic
Journal:  Front Cardiovasc Med       Date:  2017-05-05

10.  Asymptomatic Giant Aneurysm of the Left Anterior Descending Coronary Artery: A Case Report and Review of the Literature.

Authors:  Marija Bjelobrk; Slobodan Dodic; Tatjana Miljkovic; Golub Samardzija; Ilija Bjeljac; Dragana Dabovic; Biljana Dodic; Milenko Rosic; Mila Kovacevic; Aleksandar Redzek; Miklos Fabri
Journal:  J Tehran Heart Cent       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.